Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis

Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis

Background Non‐vitamin K antagonist oral anticoagulants (NOACs) have better pharmacologic properties than warfarin and are recommended in preference to warfarin in most patients with non‐valvular atrial fibrillation. Besides lower bleeding complications, other advantages of NOACs over warfarin parti...

Full description

Bibliographic Details
Main Authors: Patita Sitticharoenchai, Kullaya Takkavatakarn, Smonporn Boonyaratavej, Kearkiat Praditpornsilpa, Somchai Eiam‐Ong, Paweena Susantitaphong
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute kidney injury
end‐stage renal disease
NOACs
non‐valvular atrial fibrillation
renal outcomes
warfarin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.019609

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.019609

Similar Items